# Tellus Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tellus-therapeutics

- Industry: Biotechnology
- Headquarters: Hillsborough, US
- Website: www.tellustherapeutics.com
- Total disclosed funding: $16M
- Latest round: Series A (Nov 17, 2022)
- Investors on record: 1

## About

Based in North Carolina, US, and founded in 2018 by Eric Benner, and Jason Kralic (CEO), Tellus Therapeutics, Inc. operates as a biotechnology company that creates safe and effective treatments for newborns. In May 2021, Tellus Therapeutics, Inc. raised USD 2 million in seed funding from Xontogeny, LCC.

Tellus Therapeutics, Inc. helps to stimulate the injury in premature babies, letting doctors treat newborns for brain injury and work on improving neurodevelopmental outcomes for affected children. Furthermore, the company is focused on building, funding, and demonstrating the quality and safety of new medical approaches in newborns.

The company plans to use the funding to develop the first treatment for newborns with white matter brain injury.

## Funding rounds

- Series A, Nov 17, 2022, $16M — Perceptive Advisors

## Investors

- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series A